Fig. 2From: The prognostic impact of mutations in spliceosomal genes for myelodysplastic syndrome patients without ring sideroblastsClinical outcomes are affected by the mutation status of spliceosomal genes. Kaplan-Meier analysis of overall survival a–c, progression-free survival d–f, and probability of AML transformation g–i for the total MDS patient cohort (n = 129), stratified according to SF3B1, U2AF1, and SRSF2 mutation status. AML, acute myeloid leukemia; wt, wild-type; mut, mutantBack to article page